Southampton Scientist Verifies Effectiveness of Arthritis Drug in Slowing Alzheimer’s Progression

Southampton Scientist Verifies Effectiveness of Arthritis Drug in Slowing Alzheimer’s Progression
Arthritis drug for Alzheimer’s therapyA drug prescribed for the treatment of arthritis is able to slow the progression of Alzheimer's, according a study performed by researchers at the University of Southampton in the United Kingdom. Etanercept was administrated to patients with mild to moderate disease, and within a six-month period, the scientists verified that the disease did not get worse. The results of the study, led by Professor Clive Holmes, considered the memory function, efficiency of day-to-day activities, and behavior, and showed that the patients treated with the arthritis drug did not see their Alzheimer's disease evolve, compared to the ones treated with placebo, who did get worse. Both groups, totaling 41 patients, enrolled in a small randomized control study and were administrated ether the drug or a placebo for six months. “Our results are better than we expected," said Professor Clive Holmes, who presented the results at the Alzheimer's Association International Conference, in Denmark, between July 12th and 17th. "We have shown that using Etanercept in patients who have Alzheimer’s disease would be safe and has positive outcomes after six months. However this is a small study and should now be tested in a larger clinical trial.”
Subscribe or to access all post and page content.